myPHteam

Are you wondering about experiences with Tyvaso DPI for PH-ILD?

Great news that your insurance approved it! Tyvaso DPI (treprostinil) is actually a significant treatment option for you. The FDA recently approved an inhaled version of treprostinil specifically for treating PH caused by interstitial lung disease, making it Show Full Answer

Are you wondering about experiences with Tyvaso DPI for PH-ILD?

Great news that your insurance approved it! Tyvaso DPI (treprostinil) is actually a significant treatment option for you. The FDA recently approved an inhaled version of treprostinil specifically for treating PH caused by interstitial lung disease, making it the first FDA-approved treatment for group 3 PH.

This is an inhaled medication that works as a prostacyclin therapy. It helps widen the blood vessels in your lungs, which can reduce the pressure and make it easier for your heart to pump blood through them.

Common things to know about inhaled prostacyclin therapies:

- They're typically taken multiple times throughout the day using an inhalation device
- Side effects can include cough, headache, throat irritation, or flushing
- Some people experience nausea or jaw pain
- It may take time to adjust to the medication and find the right dose

Since this is a relatively newer approval for PH-ILD specifically, you might find fewer members with this exact experience, but many have used other forms of Tyvaso or prostacyclin therapies.

It's encouraging that you have access to this treatment option. Keep in close contact with your healthcare team as you start, especially to monitor any side effects or breathing changes.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Prostanoids for Pulmonary Hypertension

Hypoxia-Induced Pulmonary Hypertension